A detailed history of Gsa Capital Partners LLP transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 12,655 shares of STVN stock, worth $327,258. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,655
Previous 19,670 35.66%
Holding current value
$327,258
Previous $402,000 23.13%
% of portfolio
0.02%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 22, 2025

SELL
$18.57 - $25.25 $130,268 - $177,128
-7,015 Reduced 35.66%
12,655 $309,000
Q1 2025

May 08, 2025

BUY
$18.11 - $24.11 $356,223 - $474,243
19,670 New
19,670 $402,000
Q3 2023

Nov 15, 2023

BUY
$26.91 - $35.49 $935,391 - $1.23 Million
34,760 New
34,760 $1.03 Million
Q4 2022

Feb 13, 2023

BUY
$13.95 - $19.28 $293,201 - $405,227
21,018 New
21,018 $378,000

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $6.85B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.